The sales are small relative to market cap and consistent with routine portfolio management by early investors. No immediate concern, but monitor for follow-up filings or broader insider selling trends.
Price Chart
Executive Summary
Two institutional affiliates of Atlas Venture—Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P.—filed notices to sell a combined 3,135 shares of Kymera Therapeutics (KYMR) stock, valued at approximately $281,742. The filings were submitted on the same day, signaling coordinated intent to divest small positions.
Key Facts
- Atlas Venture Fund X, L.P. intends to sell 2,750 shares, valued at $247,142.50.
- Atlas Venture Opportunity Fund I, L.P. intends to sell 385 shares, valued at $34,599.95.
- Total proposed sale: 3,135 shares worth $281,742.45.
- Sales are planned through Merrill Lynch on Nasdaq, with filing dates of April 15, 2026.
- Both funds are affiliated with Atlas Venture, a founding investor in Kymera.
Financial Impact
Approximately $281,742 in potential near-term selling pressure; minimal relative to Kymera's $7.3B market cap.
Risk Factors
- Perception of waning confidence if additional insiders file similar notices.
- Potential for short-term price pressure if sales execute during low liquidity periods.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (KYMR) — Batch item 1 | 0001628280-26-025280 |
| Document: 0001628280-26-025280-index.html | 0001628280-26-025281 |
| Document: 0001628280-26-025280.txt | 0001628280-26-025280 |
| 144 Filing (KYMR) — Batch item 4 | 0001628280-26-025281 |
| Document: 0001628280-26-025281-index.html | 0001628280-26-025280 |
| Document: 0001628280-26-025281.txt | 0001628280-26-025280 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 14w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access